EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 3-Jun-2026 11:16 ET (3-Jun-2026 15:16 GMT/UTC)

AGS honors Dr. Thomas Cudjoe with Arti Hurria Memorial Award for research on the health effects of social isolation among older adults

American Geriatrics Society
Grant and Award Announcement

Today, @AmerGeriatrics awards Dr. Thomas Cudjoe, MD, MPH, MA, the Arti Hurria Memorial Award for Emerging Investigators in Internal Medicine focused on #Geriatrics #AGS26 https://bit.ly/3PMtqV1

Mount Sinai study finds lung cancer surgery safe for many patients over 80

The Mount Sinai Hospital / Mount Sinai School of Medicine
Peer-Reviewed Publication

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have found that adults aged 80 and older with early-stage lung cancer can safely undergo surgery and achieve outcomes comparable to younger patients, challenging longstanding assumptions about age and cancer treatment.

Journal: The Lancet Regional Health - Americas

University of Cincinnati announces new Center for Public Health

University of Cincinnati
Business Announcement

Following an extensive national search, the University of Cincinnati College of Medicine has appointed Suzanne E. Judd, PhD, as the inaugural director of its newly established Center for Public Health. Judd, a renowned epidemiologist and interdisciplinary scholar, will lead the center’s mission to transform community health through innovative research, education and strategic advocacy.

Registrations open for São Paulo School of Advanced Science on Regulatory Governance

Fundação de Amparo à Pesquisa do Estado de São Paulo
Meeting Announcement

School at the Getulio Vargas Foundation (Brazil) covers emerging regulatory frontiers, including central banks in climate risk regulation and antitrust in digital markets. Apply by April 30.

Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

First-in-class dual HIF inhibitors eliminate breast, colorectal, melanoma, and prostate tumors in mice when combined with immunotherapy

Rockefeller University Press
Peer-Reviewed Publication

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, first-in-class drugs that inhibit hypoxia-inducible factors 1 and 2, a pair of transcription factors considered to be “master regulators” of cancer progression. The study, to be published April 2 in the Journal of Experimental Medicine (JEM), shows that these drugs, when combined with immunotherapy, can completely eliminate breast, colorectal, melanoma, and prostate tumors in mice, suggesting that they could eventually be used to treat a broad range of cancers in humans.

Journal: Journal of Experimental Medicine
Funder: Armstrong Family Foundation

Influenza vaccine could protect against heart attack and stroke even among people who get infected

European Centre for Disease Prevention and Control (ECDC)
Peer-Reviewed Publication

A study in Denmark found that while influenza increased the risk of cardiovascular events such as acute myocardial infarction and stroke, this risk was halved among vaccinated people who got the infection.

Journal: Eurosurveillance

JMIR Publications highlights "moltbook" risks: The dangers of AI-to-AI interactions in health care

JMIR Publications
Peer-Reviewed Publication

JMIR Publications today announced the release of a timely new article in its News and Perspectives section, examining the emerging risks of autonomous AI systems interacting within clinical environments.

Journal: Journal of Medical Internet Research

Mount Sinai performs first-in-the-world liver cancer treatment using more flexible scheduling approach

The Mount Sinai Hospital / Mount Sinai School of Medicine
Business Announcement

Mount Sinai Health System has become the first health system in the world to use a minimally invasive treatment system offering newly cleared by the Food and Drug Administration, that delivers radiation directly to liver tumors through the bloodstream.

JMIR Publications and Jisc announce renewal of flat-fee unlimited open access partnership for 2026-2027

JMIR Publications
Business Announcement

JMIR Publications, a leading open-access digital health research publisher, and Jisc, the United Kingdom's not-for-profit organization providing digital services for research and education, are pleased to announce the renewal of their Flat-Fee Unlimited Open Access Publishing Agreement for 2026-2027.